All News #Library
Rare Diseases
Faron Unveils Updated BEXMAB Data in High-Risk MDS at ASH 2025
08 Dec 2025 //
PHARMIWEB
Faron Receives FDA Orphan Drug Designation for Bexmarilimab in AML
29 Aug 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support